RECONCILE TABLET (CHEWABLE)

Land: Kanada

Sprache: Englisch

Quelle: Health Canada

Kaufe es jetzt

Gebrauchsinformation Gebrauchsinformation (PIL)
24-07-2018

Wirkstoff:

FLUOXETINE (FLUOXETINE HYDROCHLORIDE)

Verfügbar ab:

PEGASUS LABORATORIES INC

Dosierung:

8MG

Darreichungsform:

TABLET (CHEWABLE)

Zusammensetzung:

FLUOXETINE (FLUOXETINE HYDROCHLORIDE) 8MG

Verabreichungsweg:

ORAL

Einheiten im Paket:

30

Verschreibungstyp:

Prescription

Therapiegruppe:

DOGS

Produktbesonderheiten:

Active ingredient group (AIG) number: 0116847005

Berechtigungsstatus:

APPROVED

Berechtigungsdatum:

2018-07-24

Gebrauchsinformation

                                PRODUCT LABEL PROFILE
_Version 2 _
_–_
_ July 12, _
_2018_
BOTTLE LABEL ENGLISH - 8 mg
Dosage and Administration:
For use in dogs only. The
recommended dose of Reconcile
chewable tablets is 1-2 mg/kg
administered once daily, in conjunction
with a behaviour modification plan.
Storage:
Store at 20-25°C; excursions permitted
between 15-30°C. Do not remove
desiccant canister from the bottle.
Completely close bottle between uses.
Pegasus Laboratories, Inc.
8809 Ely Road
Pensacola, FL USA 32514
CA4203
DIN 02307952
PR
RECONCILE®
fluoxetine (as fluoxetine hydrochloride) chewable tablets
For Veterinary Use Only
A selective serotonin reuptake inhibitor (SSRI)
for the treatment of canine
SEPARATION ANXIETY
in conjunction with a behaviour modification plan
8
mg
4.0-8.0 kg
Net: 30 Tablets
For complete product information,
see package insert.
Imported and distributed by:
_To be determined_
_ _
®
Pegasus Laboratories, Inc.
Warnings: Not for use in humans.
Keep out of reach of children.
Logo
LOT
EXP
PRODUCT LABEL PROFILE
_Version 2 _
_–_
_ July 12, _
_2018_
BOTTLE LABEL FRENCH - 8 mg
CA4203
PR
RECONCILE®
DIN 02307952
Veuillez consulter la notice
d
’
accompagnement pour obtenir
des renseignements complets sur
le produit.
fluoxétine (sous forme de chlorhydrate de fluoxétine)
comprimés à
croquer
Pour usage veterinaire seulement
Un inhibiteur sélectif du recaptage de la sérotonine
(ISRS)
pour le traitement de
l'ANXIÉTÉ DE SÉPARATION
chez le chien en concomitance avec un
programme de modification du
comportement
8 mg
4,0 à 8,0 kg
Net : 30 comprimes
Logo
LOT
EXP
PRODUCT LABEL PROFILE
_Version 2 – July 12, 2018_
FRONT PANEL ENGLISH - CARTON 8 mg
CA4203
DIN 02307952
Dog Logo
PR
RECONCILE
®
FLUOXETINE (AS FLUOXETINE HYDROCHLORIDE) CHEWABLE TABLETS
For Veterinary Use Only
A selective serotonin reuptake inhibitor (SSRI) for
the treatment of canine SEPARATION
ANXIETY
in conjunction with a behaviour modification plan
8 mg
4.0-8.0 kg
Net: 30 Tablets, 8 mg each
Logo
WARNINGS: NOT FOR USE IN HUMANS. KEEP
OUT OF REACH OF 
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Dokumente in anderen Sprachen

Gebrauchsinformation Gebrauchsinformation Französisch 24-07-2018

Suchen Sie nach Benachrichtigungen zu diesem Produkt